Effect of Caudal Nalbuphine on Postoperative Emergence Agitation in Pediatrics Undergoing Infra-umbilical Surgeries
NCT ID: NCT05245721
Last Updated: 2022-02-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
80 participants
INTERVENTIONAL
2022-03-31
2023-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Caudal Nalbuphine on Postoperative Analgesia in Children
NCT02618876
Spinal Versus Caudal Analgesia After Pediatric Infra-umbilical Surgery
NCT02988700
Nalbuphine as an Adjuvant to Levobupivacaine in Caudal Analgesia in Children
NCT05617976
Very Low Dose Caudal Morphine for Postoperative Pain Management
NCT00938821
Topical Ketamine Versus Caudal Ketamine for Postoperative Analgesia in Children Undergoing Inguinal Herniotomy
NCT02462174
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nalbuphine
Nalbuphine
Caudal nalbuphine injection in pediatrics undergoing infra-umbilical surgeries
Bupivacain
Caudal bupivacaine in pediatrics undergoing infra-umbilical surgeries
Bupivacaine
Bupivacain
Caudal bupivacaine in pediatrics undergoing infra-umbilical surgeries
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nalbuphine
Caudal nalbuphine injection in pediatrics undergoing infra-umbilical surgeries
Bupivacain
Caudal bupivacaine in pediatrics undergoing infra-umbilical surgeries
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both genders
* ASA I\_II
* Children undergoing infra-umbilical surgeries
Exclusion Criteria
* congenital anomalies at the lower spine or meringues
* Increased intracranial pressure
* Skin infection at site of injection
* Bleeding diathesis
* Known allergy to any drugs used
2 Years
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rehab Adel Ebrahim Okely
Assistant lecturer
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17101501
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.